Assignee
EVOX THERAPEUTICS LTD
GB·6 granted patents·22 pending applications·6 citations·filing 2014–2023
Top patents by PatentIndex Score
28 records- 0180US11236143B2Extracellular vesicle comprising a fusion protein having Fc binding capacityEVOX THERAPEUTICS LTD·Filed 2017·Granted Feb 1, 2022·3 cites·12 claims
- 0275US11298319B2Cell penetrating peptide (CPP)-mediated EV loadingEVOX THERAPEUTICS LTD·Filed 2017·Granted Apr 12, 2022·1 cites·6 claims
- 0375US11274139B2Therapeutic delivery vesiclesEVOX THERAPEUTICS LTD·Filed 2014·Granted Mar 15, 2022·2 cites·7 claims
- 0468US2023111666A1Therapeutic delivery vesiclesEVOX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0562US2022202714A1Cell penetrating peptide (cpp)-mediated ev loadingEVOX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0661US2023201370A1Exosomes comprising therapeutic polypeptidesEVOX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0761US2022098267A1Extracellular vesicle comprising a fusion protein having fc binding capacityEVOX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0860US11649272B2Therapeutic delivery vesiclesEVOX THERAPEUTICS LTD·Filed 2020·Granted May 16, 2023·0 cites·13 claims
- 0958US2025288695A1Tspan2 as scaffold protein for engineered extracellular vesiclesEVOX THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 1053US11534499B2Exosomes comprising therapeutic polypeptidesEVOX THERAPEUTICS LTD·Filed 2017·Granted Dec 27, 2022·0 cites·12 claims
- 1153US2025057781A1Engineered extracellular vesicles with improved cargo deliveryEVOX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1251US2022233712A1Exosome comprising stabilized rna therapeuticsEVOX THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1351US2024197908A1Modified extracellular vesicles (evs) with improved half-lifeEVOX THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1450US2023355805A1Engineered extracellular vesicles displaying enhanced pharmacokineticsEVOX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1550US2023301926A1Extracellular vesicles with improved half-lifeEVOX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1648US2023227500A1Nanoparticle-like delivery systemEVOX THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 1744US11975070B2Affinity purification of engineered extracellular vesiclesEVOX THERAPEUTICS LTD·Filed 2018·Granted May 7, 2024·0 cites·10 claims
- 1843US2021069254A1Compositions for extracellular vesicle storage and formulationEVOX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 1940US2021252164A1Combinatorial gene therapyEVOX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2040US2019224331A1METABOLIC DRUG LOADING OF EVsEVOX THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 2139US2020407418A1Cell-Mediated Exosome DeliveryEVOX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2239US2021238248A1Engineering Extracellular Vesicles for Affinity PurificationEVOX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2338US2020399591A1Protein engineered extracellular vesiclesEVOX THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 2437US2021369865A1Exosomes Comprising RNA TherapeuticsEVOX THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 2536US2021062166A1Intracellular delivery of target-silencing proteinEVOX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
- 2635US2019290585A1Ev-mediated delivery of binding protein-small molecule conjugatesEVOX THERAPEUTICS LTD·Filed 2017·Application pending·0 cites
- 2734US2020062813A1Improved Loading of EVs with Therapeutic ProteinsEVOX THERAPEUTICS LTD·Filed 2018·Application pending·0 cites
- 2834US2021386868A1Extracellular vesicles for replacement of urea cycle proteins & nucleic acidsEVOX THERAPEUTICS LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EVOX THERAPEUTICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →